220 results on '"Hitzler, Johann K."'
Search Results
2. Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431
3. Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group
4. Origin of Leukemia in Children with Down Syndrome
5. Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial
6. Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group.
7. Survival Outcomes of Children with Relapsed or Refractory Myeloid Leukemia Associated with Down syndrome
8. Abstract 2002: A genome-wide association study identifies novel sepsis risk loci in children with Down syndrome-associated acute lymphoblastic leukemia: A report from the Children’s Oncology Group
9. Outcome of Transplantation for Acute Myelogenous Leukemia in Children with Down Syndrome
10. Risks of late mortality and morbidity among survivors of childhood acute leukemia with Down syndrome: A population‐based cohort study
11. How Important Are in-Person Clinic Visits during Maintenance Therapy for Pediatric Acute Lymphoblastic Leukemia?
12. Tisagenlecleucel Therapy Is Safe and Effective for Children with Down Syndrome with ALL in First Relapse
13. Blinatumomab Associated Seizure Risk in Patients with Down Syndrome and B-Lymphoblastic Leukemia: An Interim Report from Children's Oncology Group (COG) Study AALL1731
14. Mapping the cellular origin and early evolution of leukemia in Down syndrome
15. Outcome of transplantation for acute lymphoblastic leukemia in children with down syndrome
16. Assessment of the Outcomes Associated with Periprocedural Anticoagulation Management in Children with Acute Lymphoblastic Leukemia
17. Origins of leukaemia in children with Down syndrome
18. cDNA cloning and characterization of a novel gene encoding the MLF1-interacting protein MLF1IP
19. Mapping the Cellular Origin and Early Evolution of Leukemia in Down Syndrome
20. A Human Model of Down Syndrome Associated Leukemia Reveals Different Cell of Origins for Initiation and Progression
21. Outcomes of Patients with Down Syndrome and CRLF2-Overexpressing Acute Lymphoblastic Leukemia (ALL): A Report from the Children's Oncology Group (COG)
22. Cancer among Persons with Down Syndrome
23. Risks of late mortality and morbidity among survivors of childhood acute leukemia with Down syndrome: A population‐based cohort study.
24. B cell acute lymphoblastic leukemia cells mediate RANK-RANKL–dependent bone destruction
25. High-Dose Cytarabine Is Indispensable for the Survival of Children with Myeloid Leukemia of Down Syndrome Despite Negative Minimal Residual Disease Post-Induction
26. Understanding Pre-Leukemia in Trisomy 21 Human HSC and Modeling Progression Towards Down Syndrome Associated Leukemia Using CRISPR/Cas9 at Single Cell Resolution
27. Acute Megakaryoblastic Leukemia in Down Syndrome
28. Comparison of Long-Term Neurocognitive Outcomes in Young Children With Acute Lymphoblastic Leukemia Treated With Cranial Radiation or High-Dose or Very High-Dose Intravenous Methotrexate
29. Treatment of life-threatening post-haemorrhagic anaemia with cell-free haemoglobin solution in an adolescent Jehovahʼs Witness
30. Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431
31. Inactivation of Stage-Specific B-Cell Commitment Genes Generates Distinct Molecular Subtypes of BCR-ABL1 Lymphoblastic Leukemia
32. High Vs. Low-Intensity Bridging Chemotherapy in Children with Acute Lymphoblastic Leukemia Awaiting Chimeric Antigen Receptor T-Cell Therapy: A Population-Based Study from Ontario, Canada
33. Functional and Molecular Consequences of Trisomy 21 on Human Fetal Hematopoiesis
34. Postnatally Acquired Mutations Underlie the Progression of Transient Leukemia to Myeloid Leukemia of Down Syndrome
35. The Clonal Hematopoietic Spectrum of Down Syndrome and ML-DS
36. Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo
37. Detection of a clone-specific GATA1 mutation to monitor treatment response and involvement of a monozygotic twin in myeloid leukemia of Down syndrome
38. RANK-RANKL Mediated Bone Destruction in B-Cell Acute Lymphoblastic Leukemia
39. Inflammatory Signatures Define a New High-Risk T-Lineage ALL Subtype
40. The Challenge of Treating Relapsed Myeloid Leukemia in Children with Down Syndrome - a Targeted Analysis Using Patient-Derived Xenograft Models
41. Integrative Genome and Transcriptome Sequencing Analysis Indicates Genetic and Epigenetic Dysregulation in DS-AML
42. Modeling the Multi-Step Pathogenesis of Acute Myeloid Leukemia of Down Syndrome
43. Differences of Somatic Mutations and Gene Expression in Blasts of Transient Leukemia and Acute Myeloid Leukemia of Down Syndrome
44. Improvement in Treatment Outcome and Identification of a New Prognostic Parameter in Down Syndrome Acute Myeloid Leukemia (DS-AML): Results of the Children’s Oncology Group (COG) Phase III AAML0431 Trial
45. Chapter Five - Cancer among Persons with Down Syndrome
46. Therapeutic Potential of Spleen Tyrosine Kinase Inhibition for Treating High-Risk Precursor B Cell Acute Lymphoblastic Leukemia
47. The Outcome Of Allogeneic Hematopoietic Cell Transplantation In Children With FLT3/ITD-Positive Acute Myelogenous Leukemia
48. Early Mortality In Hyperleukocytosis In Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
49. Outcome of Transplantation for Acute Leukemia in Down Syndrome
50. Outcome of Treatment for Relapsed Acute Lymphoblastic Leukemia in Children with Down Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.